Application Nr Approved Date Route Status External Links
NDA050317 None Subconjunctival None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Lincocin Sterile Solution Is Indicated In The Treatment Of Serious Infections Due To Susceptible Strains Of Streptococci, Pneumococci, And Staphylococci. Its Use Should Be Reserved For Penicillin-Allergic Patients Or Other Patients For Whom, In The Judgment Of The Physician, A Penicillin Is Inappropriate. Because Of The Risk Of Cdad, As Described In The Boxed Warning , Before Selecting Lincomycin The Physician Should Consider The Nature Of The Infection And The Suitability Of Other Alternatives. Indicated Surgical Procedures Should Be Performed In Conjunction With Antibacterial Therapy. The Drug May Be Administered Concomitantly With Other Antimicrobial Agents When Indicated. Lincomycin Is Not Indicated In The Treatment Of Minor Bacterial Infections Or Viral Infections. To Reduce The Development Of Drug-Resistant Bacteria And Maintain The Effectiveness Of Lincocin And Other Antibacterial Drugs, Lincocin Should Be Used Only To Treat Or Prevent Infections That Are Proven Or Strongly Suspected To Be Caused By Susceptible Bacteria. When Culture And Susceptibility Information Are Available, They Should Be Considered In Selecting Or Modifying Antibacterial Therapy. In The Absence Of Such Data, Local Epidemiology And Susceptibility Patterns May Contribute To The Empiric Selection Of Therapy.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Lincomycin Hydrochloride LINCOMYCIN HYDROCHLORIDE ZINC3982483

Comments